Nandu News On September 10, the board of directors of China Resources Shuanghe Pharmaceutical Co., Ltd. (600062) recently received the resignation report submitted by Guo Wei and Deng Ronghui, who applied to resign as directors and members of the special committee of the ninth board of directors of the company due to work arrangements.
According to the latest financial report, the total operating income of China Resources Shuanghe Pharmaceutical Co., Ltd. in the first half of 2021 was 4.63 billion yuan, an increase of 11.6436% year-on-year; the net profit attributable to it was 595 million yuan, an increase of 7.28% year-on-year.
China Resources Shuanghe Pharmaceutical Co., Ltd. has a glorious history of 78 years and has experienced several historic changes in China's pharmaceutical industry.
According to the Nandu Database information: Deng Ronghui, born in June 1971, bachelor's degree in engineering from Tsinghua University and master's degree in business administration from the University of Hong Kong, qualified as an engineer. He was a director and assistant general manager of China Resources Construction (Holdings) Co., Ltd., a deputy general manager of China Resources Property Co., Ltd., and an assistant director of the strategic management department of China Resources (Group) Co., Ltd. He is currently the Deputy General Manager (Deputy Director) of the Strategic Management Department of China Resources (Group) Co., Ltd., a director of China Resources Health Group Co., Ltd., China Resources Sanjiu Pharmaceutical Co., Ltd., and China Resources Shuanghe Pharmaceutical Co., Ltd.
(The above information is automatically generated by Nandu Big Data Research Institute)
![17 billion! Crus's family is amazing: Shuanghe, Sanjiu, Jiangzhong, Dong'a...[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)